Prim, S.A. operates in the Surgical appliances and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Prim, S.A. with three other
medical equipment manufacturers in Europe:
IVF Hartmann Holding AG
of Switzerland
(2018
sales of 133.38 million Swiss Francs [US$137.79 million]
of which 37%
was Infections Management),
Medartis Holding AG
of Switzerland
(121.32 million Swiss Francs [US$125.34 million]
of which 55%
was EMEA), and
Vitrolife AB
which is
based in Sweden
(1.15 billion Swedish Kronor [US$120.95 million]
of which 53%
was Media).
Sales Analysis.
Prim, S.A. reported sales of 134.11 million Euro (US$148.84 million)
for the
year ending
December of 2018.
This
represents
an
increase of 10.9%
versus 2017, when the company's sales were 120.95 million Euro.
Sales at Prim, S.A. have increased during each of the previous five years
(and since 2013, sales have increased a total of 55%).
Sales of Medical/hospitality saw an increase
of
10.9% in 2018, from
120.97 million Euro to 134.13 million Euro.
Not all segments of Prim, S.A. experienced an increase in sales in 2018:
sales of Real Estate fell 0.1% to 304,020.00 Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).